image

Authoritative Independent Monthly Share Selections Using Technical & Fundamental Analysis

Latest issue now available

CVS Group

December 2025

Investing in shares may lose you all or some of your money. Past performance is no indication of future performance. Some of the shares recommended here may be small company shares, which can be relatively illiquid and hard to trade and this makes such shares more risky than other investments.

  • Epic Code:
  • CVSG
  • Price:
  • 1200p
Buy-and-build veterinary surgeries business CVS will have been relieved that the outcome of the Competition & Markets Authority investigation into drug pricing of all the large vet chains in the UK wasn’t worse. Provisional proposals include making practices more transparent by requiring them to publish prices, providing written estimates for treatments over £500, and automatically providing written prescriptions to allow owners to buy medicine more cheaply elsewhere. The inquiry found prices have risen considerably faster than general inflation and that pet owners are often unaware of costs and have difficulty comparing services. A final decision with specific remedies is expected by March 2026 following a consultation.  Earl ...

To access our archive of articles and to receive current issues you need to subscribe.

Subscribe now

Already a subscriber? Login

With small companies there is an above average degree of risk compared to buying blue chips. Please be aware that we have not assessed the suitability of any of these investments for you. The newsletter simply states a personal view and diarises the editor’s investment decisions. Please speak to your stockbroker or other qualified individual to ascertain whether any of these companies mentioned would form useful additions to your own portfolios. Past performance is no indication of future success.

All material on this website is protected by copyright. You may use Information retrieved from the www.scsw.co.uk website for your own personal non-commercial use which means that you may not sell or copy this information to any third party without prior written consent. ISSN 1358-183X

author

LIMTED TIME OFFER

SUBSCRIBE TODAY AND SAVE £30 USING OFFER CODE 30OFFTMI

To access our archive of articles and receive current issues you need to subscribe